aspecte clinico-diagnostice - Ion Mereuta

Ion Mereuţă, Iraida Iacovlev, Oxana Pihut
133. Parini C.L., Mathis D., Leath C.A. Occult metastatic lung carcinoma
presenting as locally advanced uterine carcinosarcoma on positron emission
tomography/computed tomography imaging. In: Int. J Ginecol. Cancer. 2007 May-
June, vol. 17, nr 3, p. 731-34.
134. Pasricha R., Tiwari A., Aggarwal T. Carcinoma of uterine cervix with
isolated metastasis to fibula and its unusual behavior: report of a case and review
of literature. In: J Cancer Res. Ther. 2006, vol. 2, nr 2, p. 79-81.
135. Pasterz R., Savaraj N., Burgess M. Prognostic factors in metastatic
carcinoma of unknown primary. In: J.Clin. Oncol. 1986, vol. 4, nr 11, p.1652-1657.
136. Patel J., Nemoto T., Rosner D. Et al. Axillary lymph node metastasis from
an occult breast cancer. In: Cancer (Philad.). 1981, vol. 47, p. 2923-2926.
137. Pavlidis N., Briasoulis E., Hainsworth J. et al. Diagnostic and therapeutic
management of cancer of an unknown primary. In: En.J Cancer. 2003 Sept., vol. 39,
nr 14, p. 1990-2005.
138. Pavlidis N., Fizazi K. Cancer of unknown primary. In: Crit. Rev. Oncol.
Hematol. 2005 Jun., vol. 54, nr 3, p. 243-250.
139. Pentherondakis G., Briasoulis E., Pavlidis N. Cancer of unknown primary
site: missing primary or missing biology? In: Oncologist. 2007 Apr., vol. 12, nr 4,
p.418-425, Review.
140. Perchalski G.E., Hall K.L., Dewar M.A. Metastasis of unknown origin. In:
Primary Care. 1993, nr 12, p. 747-757.
141. Percodani J., Serrano E., Woisard V. et al. Metastatic cervical
adenopathies of unknown primary site. Long-term course. In: Ann. Otholaryngol.
Chir. Cervicofac. 1996, vol. 113, nr 4, p. 212-218.
142. Pereira T.C., Saad R.S., Liu Y., Silverman J.F. The diagnosis of malignancy
in effusion cytology: a pattern recognition approach. In: Adv. Anat. Pathol. 2006
Jul., vol. 13, nr 4, p. 174-84. Review.
143. Pihut Î. Metode contemporane în diagnosticul şi tratamentul bolnavilor
cu metastaze de tumori maligne fără focar primar depistat(Studiu bibliografic). In:
Info-Med. 2008, nr 2 (14), p. 11-20.
144. Pihut O., Mereuţă I. Aspecte manageriale în depistarea metastazelor
tumorilor maligne fără focar primar depistat. In: Info-Med. 2007, nr. 1(11), p. 12-15.
145. Raileanu I., Rusu V., Talbot J.N. Correlation in imaging techniques for the
early detection of bone metastases in a case of breast cancer. In: Rev. Med. Chir.
Soc. Med. Nat. Iasi. 2004, vol. 108, nr 1, p. 210-213.
146. Riccio A.I., Wodago F.M., Malaver M. Metastatic carcinoma of the long
bones. In: Am. Fam. Physichian. 2007, vol. 76, nr 10, p. 1489 -1494.
147. Rich A.R. On the frequency of occurrence of occult carcinoma of the
prostate (1934 cases). In: Int J. Epidemiol. 2007 April, vol. 36, nr 2, p. 274-277.
148. Ringerberg Q.S. Tumors of unknown origin. In: Med.Ped.Oncol. 1985,
vol. 13, nr 5, p. 301-306.
94
Aspecte clinico-diagnostice ale tumorilor maligne secundare cu focare primare necunoscute
149. Ritzel R.M., Ruf C., Schlegeh H.M. Backache as main symptom of
unknown primary cancer syndrome with a particularly severe course. In: Rofo.
2007 Feb., vol. 179, nr 2, p. 173-175.
150. Ruddon R.W., Northon S.E. Use of biological markers in the diagnosis of
cancers of unknown primary tumors. In: Sem.Oncol. 1993, vol. 20, nr 3, p. 251-260.
151. Saengnipanthkul S., Cowsuwon W. et al. Clinical diagnosis for metastatic
adenocarcinoma of spine of unknown origin. In: Spine. 1991, vol.16, nr 4, p. 473-474.
152. Schapira D.V., Jarrett A.R. The need to consider survival, outcome and
expense when evaluating and treating patients with unknown primary carcinoma.
In: Arch.Intern.Med. 1995 Oct.23, vol. 155, nr 19, p. 2050-2054.
153. Schiff D., O‘Neill B.P., Suman V.J. Spinal epidural metastasis as the initial
manifestation of malignancy: clinical features and diagnostic approach. In:
Neurology. 1997 Aug., vol. 49, nr 2, p. 452-456.
154. Schlag P.M., Hanerbein M. Cancer of unknown primary site. In:
Ann.Chir.Gynaecol. 1994, vol. 83, nr 1, p. 8-12.
155. Schmalbach C.E., Miller F.R. Occult primary head and neck carcinoma.
In: Curr.Oncol. Rep. 2007 Mar., vol. 9, nr 2, p. 139-146. Review.
156. Schmidt G.P., Haug A.R., Schoenberg S.O. Whole-body MRI and PET-
CT in the management of cancer patients. In: Eur. Radiol. 2006, vol. 16, nr 6, p.
1216-1225.
157. Schmidt G.P., Kramer H., Reiser M.F. Whole-body magnetic resonance
imaging and positron emission tomography-computed tomography in oncology.
In: Top. Magn. Reson. Imaging. 2007, vol. 18, nr 3, p. 193-202.
158. Schmidt G.P., Schoenberg S.O., Schmid R. Screening for bone metastasis:
whole body MRI using a 32-channel system versus dual-modality PET-CT. In:
Eur. Radiology. 2007, vol. 17, nr 4, p. 939-949.
159. Schmidt G.P., Reiser M.F. Whole-body imaging of the musculoskeletal
system: the value of MR imaging. In: Skeletal. Radiol. 2007, vol. 36, nr 12,
p. 1109-1119.
160. Scott R.G., Doll D.C. et al. Malignant ascites for unknown origin. In:
Cancer. 1990, vol. 64, nr 3, p. 753-755.
161. Scutellari P.N., Addonisio G., Righi P. Diagnostic imaging of bone
metastases. In: Radiol. Med. (Torino). 2000, vol. 100, nr 6, p. 429-435.
162. Scutellari P.N., Antinolfi G., Galeotti R. Metastatic bone disease. Strategies
for imaging. Minerva Med. 2003, vol. 94, nr 2, p. 77-90.
163. Seddon D.J., Williams E.M. Data quality in population-based cancer
registration: an assessment of the Merseysaid and Cheshire Cancer Registry. In:
Br. J. Cancer. 1997, vol. 76, nr 5, p. 667-674.
164. Seemann M.D., Meisetschlaeger G., Gaa J. Assessment of the extent of
metastasis of gastrointestinal carcinoid tumors using whole – body PET, CT,
MRI, PET/CT and PET/MRI. In: Eur. Journal Med. Res. 2006, vol. 11, nr 2, p. 58-65.
95